Question 1

Am I eligible for this study based on my current treatment and health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice clinical trial (NCT01460745). Contact the study team or your healthcare provider for specific answers.

Question 2

How does cetuximab work with chemotherapy in my case?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice clinical trial (NCT01460745). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential benefits and risks of using cetuximab for my liver metastases?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice clinical trial (NCT01460745). Contact the study team or your healthcare provider for specific answers.

Question 4

How will this study's findings impact my treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice clinical trial (NCT01460745). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of follow-up will I need if I participate in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice clinical trial (NCT01460745). Contact the study team or your healthcare provider for specific answers.

What this study is about